Autoimmunity

Risk of immunotherapy-related narcolepsy in genetically predisposed patients: a case report of narcolepsy after administration of pembrolizumab
Yutaka Natori, Eisaku Sasaki, Shu Soeda, Shigenori Furukawa, Yusuke Azami, Emi Tokuda, Takashi Kanbayashi, Shigehira Saji

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e001164; DOI: 10.1136/jitc-2020-001164
Novel platform leveraging electronic medical record (EMR) to triage patients admitted with high-grade immune-related adverse events (irAEs) to the immune-toxicity (ITOX) service
Osama Abu-Shawer, Prabhsimranjot Singh, Eric Yenulevich, Amanda Brito, Jian Ni, Raja-Elie E Abdulnour, Shilpa Grover, Michael Manos, Peter Bowling, Nicole R LeBoeuf, Patrick Ott, F Stephen Hodi, Joseph Jacobson, Osama Rahma

Journal for ImmunoTherapy of Cancer Aug 2020, 8 (2) e000992; DOI: 10.1136/jitc-2020-000992
Checkpoint inhibitor-related renal vasculitis and use of rituximab
Omar Mamlouk, Jamie S Lin, Maen Abdelrahim, Amanda S Tchakarov, William F Glass, Umut Selamet, Maryam Buni, Noha Abdel-Wahab, Ala Abudayyeh

Journal for ImmunoTherapy of Cancer Jul 2020, 8 (2) e000750; DOI: 10.1136/jitc-2020-000750
Immune-related (IR)-pneumonitis during the COVID-19 pandemic: multidisciplinary recommendations for diagnosis and management
Jarushka Naidoo, Joshua E Reuss, Karthik Suresh, David Feller-Kopman, Patrick M Forde, Seema Mehta Steinke, Clare Rock, Douglas B Johnson, Mizuki Nishino, Julie R Brahmer

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000984; DOI: 10.1136/jitc-2020-000984
Rechallenge patients with immune checkpoint inhibitors following severe immune-related adverse events: review of the literature and suggested prophylactic strategy
John Haanen, Marc Ernstoff, Yinghong Wang, Alexander Menzies, Igor Puzanov, Petros Grivas, James Larkin, Solange Peters, John Thompson, Michel Obeid

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000604; DOI: 10.1136/jitc-2020-000604
Immunotherapy to treat malignancy in patients with pre-existing autoimmunity
Patrick Boland, Anna C Pavlick, Jeffrey Weber, Sabina Sandigursky

Journal for ImmunoTherapy of Cancer Apr 2020, 8 (1) e000356; DOI: 10.1136/jitc-2019-000356
Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study
Nieves Martinez Chanza, Wanling Xie, Majd Issa, Hannah Dzimitrowicz, Abhishek Tripathi, Benoit Beuselinck, Elaine Lam, Yousef Zakharia, Rana Mckay, Sumit Shah, Amir Mortazavi, Michael R. Harrison, Spyridon Sideris, Marina D Kaymakcalan, Sarah Abou Alaiwi, Amin H Nassar, Pier Vitale Nuzzo, Anis Hamid, Toni K Choueiri, Lauren C Harshman

Journal for ImmunoTherapy of Cancer Mar 2020, 8 (1) e000538; DOI: 10.1136/jitc-2020-000538
Grover’s-like drug eruption in a patient with metastatic melanoma under ipilimumab therapy
Viktor H. Koelzer, Tobias Buser, Niels Willi, Sacha I. Rothschild, Andreas Wicki, Peter Schiller, Gieri Cathomas, Alfred Zippelius, Kirsten D. Mertz

Journal for ImmunoTherapy of Cancer Dec 2016, 4 (1) 47; DOI: 10.1186/s40425-016-0151-z
Disease stabilization with pembrolizumab for metastatic acral melanoma in the setting of autoimmune bullous pemphigoid
Kristen M. Beck, Joanna Dong, Larisa J. Geskin, Vincent P. Beltrani, Richard G. Phelps, Richard D. Carvajal, Gary Schwartz, Yvonne M. Saenger, Robyn D. Gartrell

Journal for ImmunoTherapy of Cancer Dec 2016, 4 (1) 20; DOI: 10.1186/s40425-016-0123-3
Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors—an autopsy study
Viktor H. Koelzer, Sacha I. Rothschild, Deborah Zihler, Andreas Wicki, Berenika Willi, Niels Willi, Michèle Voegeli, Gieri Cathomas, Alfred Zippelius, Kirsten D. Mertz

Journal for ImmunoTherapy of Cancer Dec 2016, 4 (1) 13; DOI: 10.1186/s40425-016-0117-1

Main menu

Autoimmunity

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Autoimmunity

Pages